AUNA S.A. (AUNA)
AUNA S.A. (AUNA) is a healthcare company providing integrated diagnostics, medical imaging, laboratory services, and outpatient care across Latin America, primarily in Peru, Mexico, and Colombia.
What the company does
AUNA operates a network of diagnostic and medical imaging centers, laboratory facilities, and outpatient clinics across Peru, Mexico, and Colombia. The platform combines multi-modality diagnostics (CT, MRI, ultrasound, X-ray), clinical laboratories, and primary care services to serve both insured and out-of-pocket patients. The company operates under various brand names depending on geography, maintaining a decentralized model adapted to local market conditions.
How it makes money
The company generates revenue principally through patient fees for diagnostic imaging, laboratory testing, and outpatient consultations. Revenue streams include direct patient payments, insurance reimbursements, and contracted arrangements with health plans and employers. The mix varies by country, with Peru contributing the largest share of consolidated revenue.
Where it sits in its industry
AUNA competes in the fragmented Latin American diagnostics and outpatient care sector, where private healthcare providers compete with public systems and small regional operators. The company’s geographic diversity and multi-modality service offering position it among the larger private diagnostic chains in its markets, though it faces competition from international hospital groups and regional players in each territory.
Capital structure and financial reporting
As a US-listed company, AUNA files SEC documents including 10-K annual reports and quarterly 10-Q filings. These documents provide comprehensive detail on revenue by geography, operating expenses, capital expenditures, and balance sheet composition. Investors can access filing history via the SEC’s EDGAR database using CIK 1799207.
Key considerations for investors
Healthcare platform companies in emerging markets operate with distinct risk profiles: regulatory environments shift more frequently, insurance payment systems vary, and currency exposure affects cross-border consolidation. AUNA’s presence across multiple countries provides diversification but also operational complexity. The diagnostics and imaging business model typically generates recurring revenue through patient volume and billing cycles, though economic cycles and healthcare spending patterns influence demand. Competitive pressure from well-capitalized hospital groups and changing reimbursement rates shape margins.